Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 3, 2008, Pages 235-240

  Alencar, R S M ^a   Gomes, M M S ^a   Sitnik, R ^b   Pinho, J R R ^a,b   Malta, F M ^a   Mello, I M V G C ^a,c   Mello, E S ^a   Bacchella, T ^a   Machado, M C C ^a   Alves, V A F ^a   Carrilho, F J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

HCV genotypes; Hepatitis C virus; Hepatocellular carcinoma; Occult hepatitis B

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PATIENT CODING; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; VIRUS CARCINOGENESIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 3;

EID: 44449155232     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006005000197     Document Type: Article

References (40)

1. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002: 9: 243-257.
2. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S. Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001, 34: 194-203.
3. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 2001: 34: 1027-1034.
4. Tamori A, Nishiguchi S, Kubo S, Enomoto M, Koh N, Takeda T, et al. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection. J Med Virol 2003; 69: 475-481.
5. Murakami Y, Minami M, Daimon Y. Okanoue T. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol 2004; 72: 203-214.
6. Yotsuyanagi H. Yasucla K, Moriya K, Shintani Y, Fujie H, Tsutsumi T. et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001; 41: 1093-1099.
7. Rumi MG, Colombo, M, Romeo R, Colucci G, Gringeri A, Mannucci PM. Serum hepatitis B virus DNA detects cryptic hepatitis B virus infections in multitransfused hemophilic patients. Blood 1990; 75: 1654-1658.
8. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-26.
9. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R, et al. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 2000; 31: 507-512.
10. Rodriguez-Inigo E, Mariscal L, Bartolome J, Castillo I, Navacerrada C. Ortiz-Movilla N, et al Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection. J Med Virol 2003; 70: 571-580.
11. De Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, Harig J. et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000, 95: 3529-3536.
12. Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Ansaldi F, et al. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients. Liver Int 2003; 23: 12-18.
13. Squadrito G, Orlando ME, Pollicino T, Raffa G, Restuccia T, Cacciola I, et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002; 97: 1518-1523.
14. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002, 40: 4068-4071.
15. Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT. Bevilacqua P, et al. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol 2004: 29: 160-166.
16. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000; 62: 151-158.
17. Ding X, Park YN, Taltavull TC, Thung SN, Jin X, Jin Y, et al. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Jpn J Infect Dis 2003; 56: 12-18.
18. Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, et al. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol 2003; 71: 492-498.
19. Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, et al. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma. Surg Today 2004, 34: 842-848.
20. Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol 2004; 11: 18-25.
21. Carrilho FJ, Corrêa MCJM. Magnitude of hepatitis B and C in Latin America. In: Schinazi RF. Sommadossi JP, Thomas HC (Editors). Therapies for viral hepatitis. Atlanta: International Medical Press; 1998. p 25-34.
22. Santos EA, Yoshida CF, Rolla VC, Mendes JM, Viera IF, Arabe J, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003: 22: 92-98.
23. Goncales FL Jr, Pereira JS, Da Silva C, Thomaz GR, Pavan MH, Fais VC, et al. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus. Clin Diagn Lab Immunol 2003; 10: 718-720.
24. Souza LO, Pinho JR, Carrilho FJ, da Silva LC. Absence of hepatitis B virus DNA in patients with hepatitis C and non-A-E hepatitis in the State of São Paulo, Brazil. Braz J Med Biol Res 2004; 37: 1665-1668.
25. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
26. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
27. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7: 660-664.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
29. Campiotto S, Pinho JR, Carrilho FJ, da Silva LC, Souto FJ, Spinelli V, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005; 38: 41-49.
30. Dakhama A, Macek V, Hogg JC, Hegele RG. Amplification of human beta-actin gene by the reverse transcriptase-polymerase chain reaction: implications for assessment of RNA from formalin-fixed, paraffin-embedded material. J Histochem Cytochem 1996; 44: 1205-1207.
31. Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, da Silva LC, Carrilho FJ. Hepatitis B virus genotypes and precore and core mutants in Brazilian patients. J Clin Microbiol 2004; 42: 2455-2460.
32. Pinho JR, Santos CA, Gonzalez CL, Bassit L, Barreto CC, Saez-Alquezar A, et al. Detection of hepatitis B virus DNA by the polymerase chain reaction in anti-HBe positive chronic hepatitis B patients. Rev Inst Med Trop São Paulo 1993; 35: 515-520.
33. Statistical Package for Social Sciences (SPSS). [Computer program]. Version 12.0. Chicago: SPSS Inc.; 2006,
34. Khristova M. Nainan O, Xia GL. False positive HBV DNA results among persons with only antibody to hepatitis B core antigen. Antiviral Ther 2000; 5 (Suppl 1): B22 (Abstract).
35. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
36. Fattovich G, Ribero ML, Pantalena M, Diodati G, Almasio P, Nevens F, et al, Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat 2001; 8: 206-216.
37. Lee CM, Lu SN, Hung CH, Tung WC, Wang JH, Tung HD, et al. Hepatitis C virus genotypes in southern Taiwan: prevalence, and clinical implications. Trans R Soc Trop Med Hyg 2006; 100: 767-774.
38. Lopez-Labrador FX, Ampurdanes S, Forns X, Castells A, Saiz JC, Costa J, et al. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997: 27: 959-965.
39. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004; 11: 383-393.
40. Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570-575.